ATE324145T1 - Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält - Google Patents

Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält

Info

Publication number
ATE324145T1
ATE324145T1 AT02714140T AT02714140T ATE324145T1 AT E324145 T1 ATE324145 T1 AT E324145T1 AT 02714140 T AT02714140 T AT 02714140T AT 02714140 T AT02714140 T AT 02714140T AT E324145 T1 ATE324145 T1 AT E324145T1
Authority
AT
Austria
Prior art keywords
paclitaxel
medicine containing
containing substituted
substituted pyrroles
anticancer medicine
Prior art date
Application number
AT02714140T
Other languages
English (en)
Inventor
Lars Holger Breimer
Kapil Dhingra
Urvashi Hooda Dhingra
Steve Ritland
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE324145T1 publication Critical patent/ATE324145T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02714140T 2001-02-09 2002-02-01 Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält ATE324145T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26787401P 2001-02-09 2001-02-09

Publications (1)

Publication Number Publication Date
ATE324145T1 true ATE324145T1 (de) 2006-05-15

Family

ID=23020488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02714140T ATE324145T1 (de) 2001-02-09 2002-02-01 Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält

Country Status (17)

Country Link
US (1) US6548531B2 (de)
EP (1) EP1359979B1 (de)
JP (1) JP4128872B2 (de)
KR (1) KR100542069B1 (de)
CN (1) CN1265786C (de)
AR (2) AR035429A1 (de)
AT (1) ATE324145T1 (de)
AU (1) AU2002246080B2 (de)
BR (1) BR0206954A (de)
CA (1) CA2435921C (de)
DE (1) DE60210926T2 (de)
DK (1) DK1359979T3 (de)
ES (1) ES2261648T3 (de)
MX (1) MXPA03007036A (de)
PT (1) PT1359979E (de)
WO (1) WO2002064214A2 (de)
ZA (1) ZA200305967B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157443A0 (en) * 2001-03-14 2004-03-28 Bristol Myers Squibb Co Pharmaceutical compositions for the treatment of cancer including an epothilone analog and a chemotherapeutic agent
JP2004532245A (ja) * 2001-05-15 2004-10-21 ページ ダブル フォーク 癌を治療するための生体影響性化合物の標的送達
JP2004537515A (ja) * 2001-05-15 2004-12-16 フォーク ファーマシューティカルス，インク． ウィルス感染症治療用薬物のターゲッティング送達
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
KR20070114753A (ko) * 2005-02-18 2007-12-04 아브락시스 바이오사이언스 인크. 치료제의 조합 및 투여 방식, 및 조합 요법
EP3141245A1 (de) 2010-03-29 2017-03-15 Abraxis BioScience, LLC Verfahren zur behandlung von karzinomen
MX2012011155A (es) 2010-03-29 2012-12-05 Abraxis Bioscience Llc Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos.
MX347225B (es) 2010-06-04 2017-04-19 Abraxis Bioscience Llc * Metodos de tratamiento contra el cancer pancreatico.
TW201613576A (en) 2014-06-26 2016-04-16 Novartis Ag Intermittent dosing of MDM2 inhibitor
WO2018092020A1 (en) 2016-11-15 2018-05-24 Novartis Ag Dose and regimen for hdm2-p53 interaction inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US6080777A (en) * 1992-01-31 2000-06-27 The Trustees Of Columbia University In The City Of New York Taxol as a radiation sensitizer
CA2086874E (en) 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
CA2140653A1 (en) * 1992-08-12 1994-03-03 Irene Abraham Protein kinase inhibitors and related compounds combined with taxol
PT1064279E (pt) 1998-03-17 2003-10-31 Hoffmann La Roche Bisindolilmaleimidas substituidas para a inibicao da proliferacao celular
WO1999055321A1 (en) * 1998-04-24 1999-11-04 Mitokor Compounds and methods for treating mitochondria-associated diseases
US6277844B1 (en) * 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6335194B1 (en) * 1998-09-29 2002-01-01 Isis Pharmaceuticals, Inc. Antisense modulation of survivin expression

Also Published As

Publication number Publication date
WO2002064214A3 (en) 2003-05-30
AU2002246080C1 (en) 2002-08-28
ZA200305967B (en) 2005-01-26
CN1491126A (zh) 2004-04-21
DK1359979T3 (da) 2006-08-28
AR098745A2 (es) 2016-06-08
MXPA03007036A (es) 2003-11-18
CN1265786C (zh) 2006-07-26
EP1359979A2 (de) 2003-11-12
PT1359979E (pt) 2006-08-31
WO2002064214A8 (en) 2004-02-19
BR0206954A (pt) 2004-02-25
US20020156118A1 (en) 2002-10-24
JP2004517961A (ja) 2004-06-17
KR20040025894A (ko) 2004-03-26
US6548531B2 (en) 2003-04-15
WO2002064214A2 (en) 2002-08-22
JP4128872B2 (ja) 2008-07-30
AR035429A1 (es) 2004-05-26
EP1359979B1 (de) 2006-04-26
CA2435921C (en) 2009-12-22
DE60210926D1 (de) 2006-06-01
ES2261648T3 (es) 2006-11-16
AU2002246080B2 (en) 2006-08-10
CA2435921A1 (en) 2002-08-22
KR100542069B1 (ko) 2006-01-11
DE60210926T2 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
CY2014008I2 (el) Παραγωγα κιναζολινης, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδους για την παραγωγη τους
ATE368041T1 (de) Neue pyrrolderivate als pharmazeutische mittel
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
DE60008981D1 (de) DPP enthaltende konjugierte Polymere und elektrolumineszente Vorrichtungen
HUP0401718A3 (en) Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them
DE60023792D1 (de) Karmin und Karamel enthaltende selbstbräunende Zusammensetzung
ATE438639T1 (de) 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel
ATE401859T1 (de) Vorrichtungen zur verabreichung von arzneistoffen mit antiprogestinischen eigenschaften
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
DE60141465D1 (de) Verschluss und Doppelbehälter
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
ATE324145T1 (de) Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält
NO20020531D0 (no) Beta-carbolin medikament produkter
ATE320256T1 (de) Succinate des 5,8,14-triazatetracyclo(10.3.1.0 2, 11 .0 4,9 )-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
ATE428695T1 (de) Spirocyclische 3-phenyl-3-substituierte-4- ketolaktame und -laktone
IL150905A0 (en) Andrographolide derivatives and pharmaceutical compositions containing the same
DE50206476D1 (de) Cyanoanthranylamid-derivate und deren verwendung als arzneimittel
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
EP1476174A4 (de) Pharmazeutische zubereitung mit einem prophylaktischen effekt auf krankheitsrückfälle und pharmokoresistenz im zusammenhang mit lamivudin und methoden zu ihrer verwendung
HUP0302648A3 (en) Bicyclic heteroaromatic compounds, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1359979

Country of ref document: EP